Close Menu

Precision Medicine Initiative

NIH Director Francis Collins; FDA Commissioner Robert Califf

With NIH funds, organizations will build the 1 million volunteer cohort, while FDA's draft guidances will inform regulation of genetic tests critical for precision medicine.

Drug developers and genetic testing firms are contemplating how best to share variant classification data while protecting their commercial interests.

The proposed bill would provide the agency with a $2 billion budget increase for the second year in a row after more than a decade of stagnant funding.

Within the consortium community healthcare systems can contribute and access each other's data on cancer patients' molecular profiles and treatment outcomes.

The agency said it would disperse the funds to the clinic over the course of five years to collect, store, and distribute biospecimens for precision medicine research.

Researchers outlined nine regulatory research-related challenges to validating, advancing, and improving next-generation sequencing-based diagnostic tests.

eric dishman

"I'm on this planet thanks to being an early prototype of precision medicine myself," said Eric Dishman, who the NIH has picked to lead the PMI Cohort Program.

Since the PMI will take some time and more funds to implement, experts believe legislation is needed to ensure the project has continued support.

The company intends to provide no-cost subscriptions to the Cloudera platform for storage, processing, and analyzing big data to researchers at some 50 institutions.

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

Pages

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.